logo
  

Clever Leaves Gets EU GMP Certification For Its Colombian Marijuana Operations

Multinational cannabis company Clever Leaves said it has received European Union Good Manufacturing Practices or EU GMP certification by the Croatian Agency for Medicinal Products and Medical Devices or HALMED.

The company obtained the certification for its pharmaceutical post-harvest facility and laboratory located outside Bogota, Colombia, to produce Active Pharmaceutical Ingredients or API, semi-finished and finished cannabis products for medical purposes.

The certification recognizes that Clever Leaves' production facilities comply with quality standards and production guidelines required by the EU for the manufacturing of cannabis and hemp-based pharmaceutical products.

According to Clever Leaves, its Colombian facility is the first medical cannabis facility to receive EU GMP certification in Latin America.

EU GMP certification is generally required to import medical cannabis products into the European Union. Clever Leaves said it expects the certification to broaden its ability to serve international markets.

"EU GMP certification greatly expands Clever Leaves' ability to serve the burgeoning European medical cannabis and hemp markets, which have very strict quality, compliance and regulatory requirements. EU GMP certification expands an early mover advantage for Clever Leaves in the pharmaceutical channel as global demand increases and more legal cannabis geographies emerge," said Kyle Detwiler, CEO of Clever Leaves.

Clever Leaves has 1.8 million square feet of current cultivation capacity in Colombia and extraction capacity of 108,000 kilograms per year, in addition to a pre-licensed cultivation operation in Portugal.

To date, the company has exported products to Australia, Brazil, Canada, Germany, Great Britain, Poland and the U.S.

Clever Leaves is the first and only Colombian cannabis company to be GMP certified by INVIMA, the Colombian food and drug agency, and is also the first to receive Good Agricultural and Collecting Practices or GACP certification in the Americas by the Control Union´s Medical Cannabis Standard (CUMCS).

In June, Clever Leaves said it intends to list on the Nasdaq through a merger with Schultze Special Purpose Acquisition Corp. (SAMA, SAMAW, and SAMAU).

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Electric vehicle maker Tesla Inc. revealed that it will lay off 285 workers from its Buffalo, New York workforce. The planned job cuts represent 14 percent of the total workforce of 2,032 workers in the region. The job cuts are part of the massive layoffs the company recently announced. In a related development, reports said citing an internal email sent to employees, that Tesla Chief Executive... The U.S. Commerce Department is preparing to fund $6.1 billion to US chip maker Micron Technology Inc. as part of the Government's plan to boost domestic semiconductor production, Bloomberg reported citing people familiar with the matter. The award is yet to get final approval, and will be revealed next week. In pre-market activity on the Nasdaq, Micron shares were gaining around 2 percent. Shares of ABB Ltd. were gaining around 6 percent in the morning trading in Switzerland after the Swiss engineering company on Thursday reported higher Operational EBITA, a key earnings metric, in its first quarter. Meanwhile, net profit and orders were lower and revenues were nearly flat. The company said its order intake for the first quarter was better than expected.

Inflation data from the U.S. garnered maximum attention this week on the economics front, along with the interest rate decision by the European Central Bank. Read our stories to find out how these two key events are set to influence monetary policy in the months ahead. Other main news from the U.S. were the release of the minutes of the latest Fed policy session and the jobless claims data. Elsewhere, the interest rate decision by the Bank of Canada was also in focus.

View More Videos
Follow RTT